Skip to main content

Table 2 Immunohistochemical findings for crawling-type adenocarcinomas (CRAs) and conventional differentiated adenocarcinomas (CDAs)

From: Analysis of clinicopathological and molecular features of crawling-type gastric adenocarcinoma

  CRA (%) CDA (%) P-value
Total 51 (100.0) 126 (100.0)  
Mucin phenotype    0.59
 Gastric type 19 (37.3) 35 (27.8)  
 Intestinal type 12 (23.5) 39 (31.0)  
 Mixed type 18 (35.3) 48 (38.1)  
 Null type (unclassified type) 2 (3.9) 4 (3.2)  
CDX-2    0.26
 Positive 41 (80.4) 91 (72.2)  
 Negative 10 (19.6) 35 (27.8)  
p53    0.422
 Positive 5 (9.8) 18 (14.3)  
 Negative 46 (90.2) 108 (85.7)  
β-catenin (nuclear accumulation)    <  0.01
 Positive 1 (2.0) 38 (30.2)  
 Negative 50 (98.0) 88 (69.8)  
MLH-1    0.04
 Retained 49 (96.1) 107 (84.9)  
 Loss of expression 2 (3.9) 19 (15.1)  
  1. P-values < 0.05 are in bold text